Evidence map›Paper›PMID 31296218›Full record

ArticleBMC medical genomics2019

Evaluating single-subject study methods for personal transcriptomic interpretations to advance precision medicine.

Samir Rachid Zaim, Colleen Kenost, Joanne Berghout, Francesca Vitali, Helen Hao Zhang, Yves A Lussier

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC medical genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Samir Rachid ZaimThe Center for Biomedical Informatics & Biostatistics of the University of Arizona Health Sciences, 1230 N. Cherry Ave, Tucson, AZ, 85721, USA.
Colleen KenostThe Center for Biomedical Informatics & Biostatistics of the University of Arizona Health Sciences, 1230 N. Cherry Ave, Tucson, AZ, 85721, USA.
Joanne BerghoutThe Center for Biomedical Informatics & Biostatistics of the University of Arizona Health Sciences, 1230 N. Cherry Ave, Tucson, AZ, 85721, USA.
Francesca VitaliThe Center for Biomedical Informatics & Biostatistics of the University of Arizona Health Sciences, 1230 N. Cherry Ave, Tucson, AZ, 85721, USA.
Helen Hao ZhangThe Graduate Interdisciplinary Program in Statistics, The University of Arizona, 617 N. Santa Rita Ave, Tucson, AZ, 85721, USA.
Yves A LussierThe Center for Biomedical Informatics & Biostatistics of the University of Arizona Health Sciences, 1230 N. Cherry Ave, Tucson, AZ, 85721, USA. yves@email.arizona.edu.
University of Arizona · USArizona Science Center · USCenter for Genomic Science · IT

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
University of Arizona - Banner Health Precision Medicine Initiative Cohort Enrollment CenterUG3OD023171 · OD · UNIVERSITY OF ARIZONA · PI MENON, USHA, OJO, AKINLOLU OLUSEUN · 2016 to 2017
$8.8M
Beagle: A Supercomputer for Computational Biology, Simulation, and Data AnalysisS10RR029030 · NCRR · UNIVERSITY OF CHICAGO · PI FOSTER, IAN · 2010 to 2010
$7.0M
Immuno-Genetic Basis for Human Disseminated CoccidioidomycosisU01AI122275 · NIAID · UNIVERSITY OF ARIZONA · PI GALGIANI, JOHN N, HOLLAND, STEVEN M · 2017 to 2020
$2.3M
Myofibroblasts in pulmonary fibrosis: origin, clones and KLF4F32HL132532 · NHLBI · YALE UNIVERSITY · PI RADHAMANI CHANDRAN, RACHANA · 2016 to 2018
$174k
NCI NIH HHS P30 CA023074NCRR NIH HHS S10 RR029030NHLBI NIH HHS F32 HL132532NIAID NIH HHS U01 AI122275NIH HHS UG3 OD023171
6 · The paper itself

Abstract

backgroundGene expression profiling has benefited medicine by providing clinically relevant insights at the molecular candidate and systems levels. However, to adopt a more 'precision' approach that integrates individual variability including 'omics data into risk assessments, diagnoses, and therapeutic decision making, whole transcriptome expression needs to be interpreted meaningfully for single subjects. We propose an "all-against-one" framework that uses biological replicates in isogenic conditions for testing differentially expressed genes (DEGs) in a single subject (ss) in the absence of an appropriate external reference standard or replicates. To evaluate our proposed "all-against-one" framework, we construct reference standards (RSs) with five conventional replicate-anchored analyses (NOISeq, DEGseq, edgeR, DESeq, DESeq2) and the remainder were treated separately as single-subject sample pairs for ss analyses (without replicates).

resultsEight ss methods (NOISeq, DEGseq, edgeR, mixture model, DESeq, DESeq2, iDEG, and ensemble) for identifying genes with differential expression were compared in Yeast (parental line versus snf2 deletion mutant; n = 42/condition) and a MCF7 breast-cancer cell line (baseline versus stimulated with estradiol; n = 7/condition). Receiver-operator characteristic (ROC) and precision-recall plots were determined for eight ss methods against each of the five RSs in both datasets. Consistent with prior analyses of these data, ~ 50% and ~ 15% DEGs were obtained in Yeast and MCF7 datasets respectively, regardless of the RSs method. NOISeq, edgeR, and DESeq were the most concordant for creating a RS. Single-subject versions of NOISeq, DEGseq, and an ensemble learner achieved the best median ROC-area-under-the-curve to compare two transcriptomes without replicates regardless of the RS method and dataset (> 90% in Yeast, > 0.75 in MCF7). Further, distinct specific single-subject methods perform better according to different proportions of DEGs.

conclusionsThe "all-against-one" framework provides a honest evaluation framework for single-subject DEG studies since these methods are evaluated, by design, against reference standards produced by unrelated DEG methods. The ss-ensemble method was the only one to reliably produce higher accuracies in all conditions tested in this conservative evaluation framework. However, single-subject methods for identifying DEGs from paired samples need improvement, as no method performed with precision> 90% and obtained moderate levels of recall. http://www.lussiergroup.org/publications/EnsembleBiomarker.

Indexed as

Precision MedicineGene Expression ProfilingHumansReference StandardsGenomic medicineMedical genomicsN-of-1N-of-1 studiesPrecision medicineSingle-subject studiesTranscriptome

Identifiers

PMID31296218
PMCPMC6624180
OpenAlexW2961168009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.